RESEARCH PAPER
Nitric oxide (NO) expression in co-culture of colon tumour spheroids with normal cells after incubation with interleukin-1ß (IL-1ß) and/or camptothecin (CPT-11)
Roman Paduch 1  
 
 
More details
Hide details
1
Department of Virology and Immunology, Institute of Microbiology and Biotechnology, Maria Curie-Skłodowska University, Lublin, Poland
CORRESPONDING AUTHOR
Roman Paduch   

Institute of Microbiology and Biotechnology, Department of Virology and Immunology, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, Poland.
 
J Pre Clin Clin Res. 2009;3(1):42–44
KEYWORDS
ABSTRACT
The present study was performed to assess the influence of IL-1β and/or camptothecin (CPT-11) on nitric oxide (NO) secretion by co-cultures of 3 human colon adenocarcinoma cell lines: HT29, LS180 and SW948, derived from different grades of tumours (Duke’s grade) cultivated as spheroids with normal human colon epithelium (CCD 841 CoTr), myofibroblasts (CCD-18Co) and endothelial cells (HUVEC). Tumour cell spheroids in monoculture produced higher amounts of NO than normal cells. In co-cultures, the level of the radical decreased compared to the sum of NO produced by tumour and normal cell monocultures. IL-1β non-significantly induced NO production in colon tumour cell spheroids and normal cell monolayers, but significantly induced the radical production in co-culture of low grade HT29 tumour cell spheroids with normal cells. CPT-11 used alone limited NO production, while in combination with IL-1β it increased the level of the radical. IL-1β and CPT-11, dependent on whether they are added separately or jointly, differentially modulate NO in monocultures of colon tumour spheroids or normal cells and their co-cultures.
 
REFERENCES (10)
1.
Rao ChV: Nitric oxide signalling in colon cancer chemoprevention. Mutat Res 2004, 555, 107-119.
 
2.
Lala PK, Chakraborty C: Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2001, 2, 149-156.
 
3.
Bonavida B, Khineche S, Huerta-Yepez S, Garban H: Therapeutic potential of nitric oxide in cancer. Drug Resist Update 2006, 9, 157- 173.
 
4.
Paduch R, Kandefer-Szerszeń M: Vitamin D, tamoxifen and β-estradiol modulate breast cancer growth and interleukin-6 and metalloproteinase-2 production in three-dimensional co-cultures of tumor cell spheroids with endothelium. Cell Biol Toxicol 2005, 21, 247-256.
 
5.
Kanzler S, Galle PR: Apoptosis and the liver. Semin Cancer Biol 2000,10, 173-184.
 
6.
Dinarello CA: The IL-1 family and infl ammatory diseases. Clin Exp Rheumatol 2002, 20, 1-13.
 
7.
Ivanova K, Lambers B, van den Wijngaard R, Le Poole IC, Grigorieva O, Gerzer R, Das PK: Immortalization of human melanocytes does not alter the de novo properties of nitric oxide to induce cell detachment from extracellular matrix components via cGMP in vitro. Cell Dev Biol Anim 2008, 44, 385-395.
 
8.
Lavnikova N, Lakhotia A, Patel N, Prokhorova S, Laskin DL: Cytostasis is required for IL-1 induced nitric oxide production in transformed hamster fi broblasts. J Cell Physiol 1996, 169, 532-537.
 
9.
Yin MB, Li ZR, Toth K, Cao S, Durrani FA, Hapke G, Bhattacharya A, Azrak RG, Frank C, Rustum YM: Potentation of irinotecan sensitivity by Se methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia inducible factor 1α expression, resulting in reduced angiogenesis. Oncogene 2006, 25, 2509-2519.
 
10.
Ohshima H, Tatemichi M, Sawa T: Chemical basis of infl ammationinduced carcinogenesis. Arch Biochem Biophys 2003, 417, 3-11.
 
eISSN:1898-7516
ISSN:1898-2395